Abstract:Purpose The recurrence of esophageal squamous cell carcinoma (ESCC) in radiation therapy treatment presents a complex challenge due to its resistance to radiation. However, the mechanism underlying the development of radioresistance in ESCC remains unclear. In this study, we aim to uncover the mechanisms underlying radioresistance in ESCC cells and identify potential targets for radiosensitization. Methods We established two radio‐resistant cell lines, TE‐1R and KYSE‐150R, from the parental ESCC cell lines TE‐1 and KYSE‐150 through fractionated irradiation. A TMT‐based quantitative proteomic profiling approach was applied to identify changes in protein expression patterns. Cell Counting Kit‐8, colony formation, γH2AX foci immunofluorescence and comet assays were utilized to validate our findings. The downstream effectors of the DNA repair pathway were confirmed using an HR/NHEJ reporter assay and Western blot analysis. Furthermore, we evaluated the expression of potential targets in ESCC tissues through immunohistochemistry combined with mass spectrometry. Results Over 2,000 proteins were quantitatively identified in the ESCC cell lysates. A comparison with radio‐sensitive cells revealed 61 up‐regulated and 14 down‐regulated proteins in the radio‐resistant cells. Additionally, radiation treatment induced 24 up‐regulated and 12 down‐regulated proteins in the radio‐sensitive ESCC cells. Among the differentially expressed proteins, S100 calcium binding protein A6 (S100A6), glutamine gamma‐glutamyltransferase 2 (TGM2), glycogen phosphorylase, brain form (PYGB), and Thymosin Beta 10 (TMSB10) were selected for further validation studies as they were found to be over‐expressed in the accumulated radio‐resistant ESCC cells and radio‐resistant cells. Importantly, high S100A6 expression showed a positive correlation with cancer recurrence in ESCC patients. Our results suggest that several key proteins, including S100A6, TGM2, and PYGB, play a role in the development of radioresistance in ESCC. Conclusions Our results revealed that several proteins including Protein S100‐A6 (S100A6), Protein‐glutamine gamma‐glutamyltransferase 2 (TGM2), Glycogen phosphorylase, brain form (PYGB) were involved in radio‐resistance development. These proteins could potentially serve as biomarkers for ESCC radio‐resistance and as therapeutic targets to treat radio‐resistant ESCC cells.

Characterization and Mechanisms of Radioresistant Lung Squamous Cell Carcinoma Cell Lines

Prognostic Biomarkers after Radiotherapy for Nonsmall Cell Lung Cancer Based on Bioinformatics Analysis

[Establishment of Human Lung Adenocarcinoma Radioresistant Cell Lines and the Mechanism of Radioresistance].

The Development of Radioresistant Oral Squamous Carcinoma Cell Lines and Identification of Radiotherapy-Related Biomarkers

Establishment of a Radioresistant Human Lung Cancer Cell Subline and Its Mechanism of Radioresistance

Radiosensitivity-Specific Proteomic and Signaling Pathway Network of Non-Small Cell Lung Cancer (NSCLC).

TMT‐Based Quantitative Proteomic Profiling of Human Esophageal Cancer Cells Reveals the Potential Mechanism and Potential Therapeutic Targets Associated With Radioresistance

Gene expression profiling of a radioresistant esophageal squamous cancer cell line

Solute Carrier Protein Family May Involve in Radiation-Induced Radioresistance of Non-Small Cell Lung Cancer

Suppresses of LIM Kinase 2 Promotes Radiosensitivity in Radioresistant Non-Small Cell Lung Cancer Cells

Fractionated irradiation induces radioresistant oral carcinoma cells with enhanced malignant phenotypes

Isolation and Characterization of Radiation-resistant Lung Cancer D6-R Cell Line

LTF Induces Radioresistance by Promoting Autophagy and Forms an AMPK/SP2/NEAT1/miR-214-5p Feedback Loop in Lung Squamous Cell Carcinoma

Molecular mechanism of radiation tolerance in lung adenocarcinoma cells using single‐cell RNA sequencing

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines.

Cdna Expression Analysis of a Human Radiosensitive-Radioresistant Cell Line Model Identifies Telomere Function As a Hallmark of Radioresistance.

Sirt3 Promoted DNA Damage Repair and Radioresistance Through ATM-Chk2 in Non-small Cell Lung Cancer Cells

Involvement of Cdc25c in Cell Cycle Alteration of A Radioresistant Lung Cancer Cell Line Established with Fractionated Ionizing Radiation

Properties and Gene Expression Profiling of Acquired Radioresistance in Mouse Breast Cancer Cells.

Global profiling of transcriptome, proteome and 2-hydroxyisobutyrylome in radioresistant lung adenocarcinoma cell

TGM2-Mediated Autophagy Contributes to the Radio-Resistance of Non-Small Cell Lung Cancer Stem-like Cells